These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1501 related items for PubMed ID: 29979618

  • 1. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
    Breton MD, Patek SD, Lv D, Schertz E, Robic J, Pinnata J, Kollar L, Barnett C, Wakeman C, Oliveri M, Fabris C, Chernavvsky D, Kovatchev BP, Anderson SM.
    Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
    [Abstract] [Full Text] [Related]

  • 2. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, Kollman C, Kruger D, McGill JB, Polonsky W, Toschi E, Wolpert H, Price D, DIAMOND Study Group.
    JAMA; 2017 Jan 24; 317(4):371-378. PubMed ID: 28118453
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH, Sapir T.
    J Manag Care Pharm; 2012 Aug 24; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
    Rossetti P, Ampudia-Blasco FJ, Laguna A, Revert A, Vehì J, Ascaso JF, Bondia J.
    Diabetes Technol Ther; 2012 Nov 24; 14(11):1043-52. PubMed ID: 23003329
    [Abstract] [Full Text] [Related]

  • 6. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D.
    Diabetes Technol Ther; 2017 Jun 24; 19(S3):S25-S37. PubMed ID: 28585879
    [Abstract] [Full Text] [Related]

  • 7. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP, Li Z, Buckingham BA, Pinsker JE, Cengiz E, Wadwa RP, Ekhlaspour L, Church MM, Weinzimer SA, Jost E, Marcal T, Andre C, Carria L, Swanson V, Lum JW, Kollman C, Woodall W, Beck RW.
    Diabetes Care; 2018 Oct 24; 41(10):2155-2161. PubMed ID: 30089663
    [Abstract] [Full Text] [Related]

  • 8. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.
    Akturk HK, Snell-Bergeon JK, Rewers A, Klaff LJ, Bode BW, Peters AL, Bailey TS, Garg SK.
    Diabetes Technol Ther; 2018 Oct 24; 20(10):639-647. PubMed ID: 30207748
    [Abstract] [Full Text] [Related]

  • 9. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP, Turksoy K, McGaugh SM, Pooni R, Vienneau T, Ly T, Riddell MC.
    Diabetes Technol Ther; 2019 Jun 24; 21(6):313-321. PubMed ID: 31059282
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
    Ólafsdóttir AF, Polonsky W, Bolinder J, Hirsch IB, Dahlqvist S, Wedel H, Nyström T, Wijkman M, Schwarcz E, Hellman J, Heise T, Lind M.
    Diabetes Technol Ther; 2018 Apr 24; 20(4):274-284. PubMed ID: 29608107
    [Abstract] [Full Text] [Related]

  • 14. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
    Moreno-Fernandez J, Gomez FJ, Gazquez M, Pedroche M, García-Manzanares A, Tenias JM, Benito P, Gomez IR.
    Diabetes Technol Ther; 2013 Jul 24; 15(7):596-600. PubMed ID: 23631604
    [Abstract] [Full Text] [Related]

  • 15. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G, Alonso GT, Snell-Bergeon JK, Shah VN.
    Diabetes Technol Ther; 2019 Jan 24; 21(1):6-10. PubMed ID: 30575413
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
    Peyser TA, Nakamura K, Price D, Bohnett LC, Hirsch IB, Balo A.
    Diabetes Technol Ther; 2015 Aug 24; 17(8):548-54. PubMed ID: 25961446
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.